Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates

References

• Finnegan L, Erlich S. Maternal drug abuse during pregnancy: Evaluation and pharmacotherapy for neonatal abstinence. Modern Methods in Pharmacological Testing and Evaluation of Drugs of Abuse, M W Adler, A Cowan. Wiley-Liss, New York 1990; 255–263
   Google Scholar
• Davis R C, Chappel J N, Mejia-Zelaya A, Madden J. Clinical observations on methadone-maintained pregnancies. Perinatal addiction, R Harbison. Spectrum, New York 1975; 101–112
   Google Scholar
• Malpas T J, Darlow B A, Lennox R, Horwood L J. Maternal methadone dosage and neonatal withdrawal. Aust N Z J Obstet Gynaecol 1995; 35: 175–177
   PubMed Web of Science ®Google Scholar
• Doberczak T M, Kandall S R, Friedmann P. Relationships between maternal methadone dosage, maternal–neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 1993; 81: 936–940
   PubMed Web of Science ®Google Scholar
• McCarthy J J, Leamon M H, Parr M S, Anania B. High-dose methadone maintenance in pregnancy: Maternal and neonatal outcomes. Am J Obstet Gynecol 2005; 93: 606–610
   Google Scholar
• Berghella V, Lim P J, Hill M K, Cherpes J, Chennat J, Kaltenbach K. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol 2003; 189: 312–317
   PubMed Web of Science ®Google Scholar
• Mack G, Thomas D, Giles G, Buchanan N. Methadone levels and neonatal withdrawal. J Paediatr Child Health 1991; 27: 96–100
   PubMed Web of Science ®Google Scholar
• Dasche J S, Sheffield J S, Olscher D A, Todd S L, Jackson G L, Wendel G D. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 2002; 100: 1244–1249
   PubMedGoogle Scholar
• Strauss M E, Andresko M, Stryker J C, Wardell J N. Relationship of neonatal withdrawal to maternal methadone dose. Am J Drug Alcohol Abuse 1976; 3: 339–345
   PubMed Web of Science ®Google Scholar
• Madden J D, Chappel J N, Zuspan F, Gumpel J, Mejia A, Davis R. Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol 1977; 127: 199–201
   PubMed Web of Science ®Google Scholar
• Ostrea E M, Chavez C J, Strauss M E. A study of factors that influence the severity of neonatal withdrawal. J Pediatr 1976; 88: 642–645
   PubMed Web of Science ®Google Scholar
• Nekhayeva I A, Nonovskaya T N, Deshmukh S V, Zharikova O L, Hankins G D, Ahmed M S. Bidirectional transfer of methadone across human placenta. Biochem Pharmacol 2005; 69: 187–197
   PubMed Web of Science ®Google Scholar
• Wolff K, Boys A, Rostami-Hodjegan A, Hays A, Raistrick D. Changes to methadone clearance during pregnancy. Eur J Clin Pharmacol 2005; 61: 763–768
   PubMed Web of Science ®Google Scholar
• Nagy E, Loveland K A, Orvos H, Molnar P. Gender-related physiologic differences in human neonates and the greater vulnerability of males to developmental brain disorders. J Gend Specif Med 2001; 4: 41–49
   PubMedGoogle Scholar
• Weinberg M, Tronick E Z, Cohn J F, Olson K L. Gender differences in emotional expressivity and self-regulation during early infancy. Dev Psychol 1999; 35: 175–188
   PubMed Web of Science ®Google Scholar
• Morse S, Wu S S, Ma C, Ariet M, Resnick M, Roth J. Racial and gender differences in the viability of extremely low birth weight infants: A population-based study. Pediatrics 2006; 117: e106–112
   PubMed Web of Science ®Google Scholar
• Anyaegbunam A, Tran T, Jadali D, Randolph G, Mikhail M S. Assessment of fetal well-being in methadone-maintained pregnancies: Abnormal non-stress tests. Gynecol Obstet Invest 1997; 43: 25–28
   PubMed Web of Science ®Google Scholar
• Levine A, Rebarber A. Methadone maintenance treatment and the nonstress test. J Perinatol 1995; 15: 229–231
   PubMedGoogle Scholar
• Archie C, Lee M I, Sokol R J, Norman G. The effects of methadone treatment on the reactivity of the nonstress test. Obstet Gynecol 1989; 74: 254–255
   PubMed Web of Science ®Google Scholar
• Cejtin H, Mills A, Swift E. Effect of methadone on the biophysical profile. J Reprod Med 1996; 41: 819–822
   PubMed Web of Science ®Google Scholar
• Wouldes T A, Roberts A B, Pryor J E, Bagnall C, Gunn T R. The effect of methadone treatment on the quantity and quality of human fetal movement. Neurotoxicol Teratol 2004; 26: 23–34
   PubMed Web of Science ®Google Scholar
• Jansson L, Elko A, DiPietro J. Fetal response to maternal methadone administration. Am J Obstet Gynecol 2005; 193: 611–617
   PubMed Web of Science ®Google Scholar
• Bazhenova O, Plonskaia O, Porges S. Vagal reactivity and affective adjustment in infants during interactive challenges. Child Dev 2001; 72: 1314–1326
   PubMed Web of Science ®Google Scholar
• Porges S, Greenspan S. Regulatory disorders. II: Psychophysiologic perspectives. NIDA Res Monogr 1991; 114: 173–181
   PubMedGoogle Scholar
• Grossman P, van Beek J, Wientjes C. A comparison of three quantification methods for estimation of respiratory sinus arrhythmia. Psychophysiology 1990; 27: 702–714
   PubMed Web of Science ®Google Scholar
• Porges S. Vagal tone: A physiologic marker of stress vulnerability. Pediatrics 1992; 90: 498–504
   PubMed Web of Science ®Google Scholar
• Porges S. Vagal tone: An autonomic mediator of affect. The development of emotion, regulation and dysregulation, J Garber, K Dodge. Cambridge University Press, New York 1991; 111–128
   Google Scholar
• Newlin D, Byrne E, Porges S. Vagal mediation of the effect of alcohol on heart rate. Alcohol Clin Exp Res 1990; 14: 421–424
   PubMedGoogle Scholar
• Newlin D B, Pretorius M B, Wong C J, Dax E M. Acute marijuana smoking reduces vagal tone. NIDA Res Monogr 1990; 105: 565–566
   PubMedGoogle Scholar
• Newlin D. Effect of cocaine on vagal tone: A common factors approach. Drug Alcohol Depend 1995; 37: 211–216
   PubMedGoogle Scholar
• Doberczak T M, Kandall S R, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 1991; 118: 933–937
   PubMed Web of Science ®Google Scholar
• The American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics 1998; 101: 1079–1088
   Google Scholar
• Kreek M. Plasma and urine levels of methadone. NY State J Med 1973; 23: 2773–2777
   Google Scholar
• Handelsman L, Cochrane K J, Aronson M J, Ness R A, Rubinstein K J, Kanof P D. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987; 13: 293–308
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Bammer G, Rushworth L, Jolley D J, Whelan G. Buprenorphine dosing regime for inpatient heroin withdrawal: A symptom-triggered dose titration study. Drug Alcohol Depend 2003; 70: 287–294
   PubMedGoogle Scholar
• Finnegan L, Connaughton J F, Kron R E, Emich J P. Neonatal abstinence syndrome: Assessment and management. Addict Dis 1975; 2: 141–158
   PubMedGoogle Scholar
• Porges S. Respiratory sinus arrhythmia: Physiological basis, quantitative methods, and clinical implications. Cardiorespiratory and cardiosomatic psychophysiology, P Grossman, K Janssen, D Vaitl. Plenum, New York 1986; 101–115
   Google Scholar
• Willett J. Measuring change: What individual growth curve modeling buys you. Change and development: Issues of theory, method and application, E Amsel, K Renninger. Lawrence Erlbaum Associates, Mahwah, NJ 1997; 213–243
   Google Scholar
• Johnson H, Rosen T. Prenatal methadone exposure: Effects on behavior in early infancy. Pediatr Pharmacol 1982; 2: 113–120
   PubMedGoogle Scholar
• Rissanen A, Naukkarinen H, Virkkunen M, Rawlings R R, Linnoila M. Fluoxetine normalizes increased cardiac vagal tone in bulemia nervosa. J Clin Psychopharmacol 1998; 18: 26–32
   PubMedGoogle Scholar
• Tanaka M, Nakahara T, Muranaga T, Kojima S, Yasuhara D, Ueno H, Nakazato M, Inui A. Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive-behavioral treatment in patients with bulimia nervosa. Horm Behav 2006; 50: 261–265
   PubMedGoogle Scholar
• Baumann P. Pharmacokinetic–pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Clin Pharmacokinet 1996; 31: 444–469
   PubMed Web of Science ®Google Scholar
• Hamilton S P, Nunes E V, Janal M, Weber L. The effect of sertraline on methadone plasma levels in methadone-maintenance patients. Am J Addict 2000; 9: 63–69
   PubMed Web of Science ®Google Scholar
• Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160: 173–176
   PubMed Web of Science ®Google Scholar
• Beaulac-Baillargeon L, Boucher N. Neonatal adverse reactions after in utero exposure to selective serotonin reuptake inhibitors: Still controversial. Arch Pediatr Adolesc Med 2006; 160: 855–856
   PubMedGoogle Scholar
• Godding V, Bonnier C, Fiasse L, Michel M, Longueville E, Lebecque P, Robert A, Galanti L. Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates?. Pediatr Res 2004; 55: 654–651
   Google Scholar
• Bornstein M, Suess P. Child and mother cardiac vagal tone: Continuity, stability and concordance across the first 5 years. Dev Psychol 2000; 36: 54–65
   PubMed Web of Science ®Google Scholar
• Finnegan L P, Kaltenbach K. Neonatal abstinence syndrome. Primary pediatric care. Second ed, R A Hoekelman, S B Friedman, N M Nelson, H M Seidel. Mosby Year Book, St Louis, MO 1992; 1367–1378
   Google Scholar